Skip to content
healthcare.dev

Omlonti

NDC 84826-002, omidenepag isopropyl, solution/ drops, from Ocuvex Therapeutics, Inc..

Product NDC
84826-002
Status
Listed
Labeler
Ocuvex Therapeutics, Inc.
Dosage form
SOLUTION/ DROPS
Route
OPHTHALMIC
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA215092
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/84826-002 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OMIDENEPAG ISOPROPYL.02 mg/mL

Pharmacologic classes

Prostaglandin E2 Receptor Agonist [EPC]; Prostaglandin E2 Receptor Agonists [MoA]

Package NDCNDC-11Package
84826-002-01848260002011 BOTTLE, PLASTIC in 1 CARTON (84826-002-01) / 2.5 mL in 1 BOTTLE, PLASTIC
84826-002-03848260002033 BOTTLE, PLASTIC in 1 CARTON (84826-002-03) / 2.5 mL in 1 BOTTLE, PLASTIC

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4258e437-7e92-4b09-baf1-01cb158cfc05

Use it

Look up 84826-002 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/84826-002 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 84826-002. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.